Qure Hematology And Oncology Center Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.00 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
About Qure Hematology And Oncology Center Llp
Qure Hematology And Oncology Center Llp (QHAOCL) is 6 Year, 10 Months old Limited Liability Partnership 02 April 2018. Its registered office is in Ahmedabad, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.00 M as per MCA.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAM-3456
-
Incorporation Date
02 Apr 2018
-
Date of Accounts and Solvency Statement
31 Mar 2023
-
ROC Code
Roc-Ahmedabad
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Qure Hematology And Oncology Center Llp?
Designated Partners (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eva Vyas
|
Designated Partner | 01-Oct-2023 | Current |
|
Jwalant Shah
|
Designated Partner | 02-Apr-2018 | Current |
|
Himal Shah
|
Designated Partner | 01-Oct-2023 | Current |
|
Ankit Raiyani
|
Designated Partner | 01-Oct-2023 | Current |
Financial Performance of Qure Hematology And Oncology Center Llp.
Enhance accessibility to Qure Hematology And Oncology Center Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qure Hematology And Oncology Center Llp?
Unlock access to Qure Hematology And Oncology Center Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Advanced Transfusion Medicine Research FoundationJwalant Shah is a mutual person
-
Unipath Specialty Laboratory (Gujarat) L LpJwalant Shah is a mutual person
-
Unipath Specialty Laboratory (Gota) Llp
Jwalant Shah is a mutual person
-
Unipath Specialty Laboratory Limited
Jwalant Shah is a mutual person
-
Baroda Diagnostics LlpEva Vyas and Jwalant Shah are mutual person
-
Greenwave Consultants Private Limited
Eva Vyas is a mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Qure Hematology And Oncology Center Llp?
Unlock and access historical data on people associated with Qure Hematology And Oncology Center Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qure Hematology And Oncology Center Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qure Hematology And Oncology Center Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
